Y. Tuncok et al., THE EFFECTS OF AMRINONE AND GLUCAGON ON VERAPAMIL-INDUCED CARDIOVASCULAR TOXICITY IN ANESTHETIZED RATS, International journal of experimental pathology, 77(5), 1996, pp. 207-212
The goal of this study was to compare the effects of glucagon and amri
none on mean arterial pressure (MAP) and heart rate, when used alone a
nd in combination, in an anaesthetized rat model of verapamil toxicity
. Fats were anaesthetized and the carotid artery was cannulated for MA
P and heart rate measurements. Jugular and femoral veins were cannulat
ed for drug administration. After verapamil infusion (15 mg/kg/h), con
trol animals were given normal saline solution and the other groups re
ceived amrinone (0.1 or 0.2 mg/kg/min), glucagon (0.3 mg/kg bolus foll
owed by 0.1 or 0.2 mg/kg/min infusion), glucagon plus amrinone (0.1 mg
/kg/min and 0.1 mg/kg/min respectively) or glucagon plus amrinone (0.2
mg/kg/min and 0.1 mg/kg/min respectively). Glucagon (0.2 mg/kg/min) s
ignificantly increased MAP when compared to the control group (P < 0.0
1). The combination of glucagon and amrinone did not produce a synergi
stic effect for the recovery of MAP. Furthermore, this combination mas
ked the positive effects of glucagon (0.2mg/kg/min) on MAP. Glucagon (
0.2mg/kg/min) increased the heart rates compared with those of the con
trol group (P < 0.05). Additionally, amrinone (0.1 mg/kg/min) plus glu
cagon (0.1 mg/kg/min) increased the heart rates (P < 0.05). Finally, g
lucagon dose dependently recovered MAP. While amrinone depressed MAP i
n combination with glucagon, it did not alter the positive chronotropi
c effect of high dose glucagon.